Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor

Eur J Med Chem. 2014 Oct 6:85:818-29. doi: 10.1016/j.ejmech.2014.07.077. Epub 2014 Aug 23.

Abstract

The neoclerodane diterpenoid salvinorin A is a major secondary metabolite isolated from the psychoactive plant Salvia divinorum. Salvinorin A has been shown to have high affinity and selectivity for the κ-opioid receptor (KOR). To study the ligand-receptor interactions that occur between salvinorin A and the KOR, a new series of salvinorin A derivatives bearing potentially reactive Michael acceptor functional groups at C-2 was synthesized and used to probe the salvinorin A binding site. The κ-, δ-, and μ-opioid receptor (KOR, DOR and MOR, respectively) binding affinities and KOR efficacies were measured for the new compounds. Although none showed wash-resistant irreversible binding, most of them showed high affinity for the KOR, and some exhibited dual affinity to KOR and MOR. Molecular modeling techniques based on the recently-determined crystal structure of the KOR combined with results from mutagenesis studies, competitive binding, functional assays and structure-activity relationships, and previous salvinorin A-KOR interaction models were used to identify putative interaction modes of the new compounds with the KOR and MOR.

Keywords: Kappa, delta, and mu opioid receptors; Michael acceptor-type ligands; Molecular modeling; Salvinorin A and B.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diterpenes, Clerodane / chemical synthesis
  • Diterpenes, Clerodane / chemistry*
  • Diterpenes, Clerodane / metabolism*
  • Drug Design*
  • HEK293 Cells
  • Humans
  • Ligands
  • Models, Molecular
  • Protein Binding
  • Protein Conformation
  • Receptors, Opioid, kappa / chemistry
  • Receptors, Opioid, kappa / metabolism*

Substances

  • Diterpenes, Clerodane
  • Ligands
  • Receptors, Opioid, kappa
  • salvinorin A